AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

India’s Pharma & Healthcare Market to 2023 - Generic Drugs Account for Around 75% of the Indian Pharmaceutical Market by Volume - ResearchAndMarkets.com

May 24, 2019

DUBLIN--(BUSINESS WIRE)--May 24, 2019--

The “India Pharma and Healthcare Sector Report 2019/2023” report has been added to ResearchAndMarkets.com’s offering.

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for India . The researcher presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

India’s is the world’s 10th-largest pharmaceutical market in US dollar terms - with sales of over USD 25bn in 2017 - and the largest generic drug manufacturer and exporter globally. Strong domestic demand and robust exports have contributed equally to growth in turnover. Generic drugs account for around 75% of the Indian pharmaceutical market by volume, as well as most of the drug production in the country.

The Indian pharmaceutical space is highly fragmented, with nearly 10,000 players. The Indian healthcare industry comprises five broad segments - Healthcare Delivery (Hospitals), Pharmaceuticals, Medical Equipment & Supplies, and Health Insurance and Diagnostics. Healthcare Delivery (Hospitals) accounted for nearly 70% of industry revenue in FY2018. Private hospitals dominate healthcare provision in the country, as public healthcare services and expenditure are highly inadequate.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in India
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in India
  • Crystallise the forces both driving and restraining this sector in India
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in India
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels)

Key Topics Covered

01 EXECUTIVE SUMMARY

  • Sector in Numbers
  • Sector Overview
  • Sector Snapshot
  • Driving Forces
  • Restraining Forces

02 SECTOR FORECAST

  • Macroeconomic Outlook
  • Economic Sentiment
  • Production and Sales
  • Exports
  • Imports

03 SECTOR IN FOCUS

  • Main Economic Indicators
  • Main Sector Indicators
  • Health Profile
  • Healthcare Expenditure
  • Health Insurance
  • Global Positioning
  • External Trade in Pharmaceuticals
  • Pharmaceutical Exports
  • Pharmaceutical Imports
  • FDI
  • Main Events

04 COMPETITIVE LANDSCAPE

  • Timeline India Pharma & Healthcare
  • Healthcare Highlights
  • Healthcare Trends
  • Top Hospitals
  • Pharmaceutical Highlights
  • Top Pharmaceutical Companies
  • Medical Device Highlights
  • Focus Point - Major Medical Device
  • Manufacturing Clusters in India
  • M&A Deals
  • M&A Activity, January 1, 2016 - December 31, 2018

05 COMPANIES IN FOCUS

  • Apollo Hospitals Enterprise Ltd
  • Fortis Healthcare Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Ltd
  • Cipla Inc
  • Dr. Reddy’s Laboratories

06 REGULATORY ENVIRONMENT

  • Government Policy

07 HEALTHCARE SERVICES

  • Highlights
  • Demand
  • Supply
  • Medical Tourism
  • Telemedicine

08 PHARMACEUTICALS

  • Highlights
  • External Trade
  • Prescription Drugs
  • OTC Drugs
  • Patented Drugs
  • Generic Drugs
  • Traditional Medicine
  • Clinical Trials

09 MEDICAL DEVICES

  • Highlights
  • External Trade
  • Consumables
  • Diagnostic Imaging
  • Patient Aids

10 RETAIL CHANNELS

  • Brick-and-Mortar Pharmacies
  • E-Pharmacies
  • Pharmacy Workforce

For more information about this report visit https://www.researchandmarkets.com/r/vac2l

View source version on businesswire.com:https://www.businesswire.com/news/home/20190524005140/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Healthcare Services,Pharmaceuticals

KEYWORD: ASIA PACIFIC INDIA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/24/2019 07:15 AM/DISC: 05/24/2019 07:15 AM

http://www.businesswire.com/news/home/20190524005140/en

All contents © copyright 2019 The Associated Press. All rights reserved.